Diabetes Mellitus, Insulin-Dependent
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
Lupus Erythematosus, Systemic
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
Psoriasis
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
Ankylosing spondylitis
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
Autoimmune thyroiditis
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
Leukemia, Myelocytic, Acute
|
0.320 |
Biomarker
|
disease |
BEFREE |
To determine whether ADCY7 supports AML development, we employed an shRNA-encoding lentivirus system to inhibit adcy7 expression in human AML cells including U937, MV4-11, and THP-1 cells.
|
26220344 |
2015 |
leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our study suggests that inhibition of ADCY7 may be novel strategy for treating leukemia.
|
26220344 |
2015 |
Childhood Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our study suggests that inhibition of ADCY7 may be novel strategy for treating leukemia.
|
26220344 |
2015 |
Depressive disorder
|
0.330 |
Biomarker
|
disease |
BEFREE |
This converging cross-species evidence implicates ADCY7 in the modulation of mood regulatory neural mechanisms and, possibly, risk for and pathophysiology of depression, together supporting a continuous dimensional approach to major depressive disorder and other affective disorders.
|
22264442 |
2012 |
Depressive disorder
|
0.330 |
Biomarker
|
disease |
PSYGENET |
This converging cross-species evidence implicates ADCY7 in the modulation of mood regulatory neural mechanisms and, possibly, risk for and pathophysiology of depression, together supporting a continuous dimensional approach to major depressive disorder and other affective disorders.
|
22264442 |
2012 |
Mental Depression
|
0.320 |
Biomarker
|
disease |
BEFREE |
This converging cross-species evidence implicates ADCY7 in the modulation of mood regulatory neural mechanisms and, possibly, risk for and pathophysiology of depression, together supporting a continuous dimensional approach to major depressive disorder and other affective disorders.
|
22264442 |
2012 |
Mental Depression
|
0.320 |
Biomarker
|
disease |
PSYGENET |
This converging cross-species evidence implicates ADCY7 in the modulation of mood regulatory neural mechanisms and, possibly, risk for and pathophysiology of depression, together supporting a continuous dimensional approach to major depressive disorder and other affective disorders.
|
22264442 |
2012 |
Unipolar Depression
|
0.320 |
Biomarker
|
disease |
PSYGENET |
This converging cross-species evidence implicates ADCY7 in the modulation of mood regulatory neural mechanisms and, possibly, risk for and pathophysiology of depression, together supporting a continuous dimensional approach to major depressive disorder and other affective disorders.
|
22264442 |
2012 |
Unipolar Depression
|
0.320 |
Biomarker
|
disease |
BEFREE |
This converging cross-species evidence implicates ADCY7 in the modulation of mood regulatory neural mechanisms and, possibly, risk for and pathophysiology of depression, together supporting a continuous dimensional approach to major depressive disorder and other affective disorders.
|
22264442 |
2012 |
Major Depressive Disorder
|
0.320 |
Biomarker
|
disease |
BEFREE |
This converging cross-species evidence implicates ADCY7 in the modulation of mood regulatory neural mechanisms and, possibly, risk for and pathophysiology of depression, together supporting a continuous dimensional approach to major depressive disorder and other affective disorders.
|
22264442 |
2012 |
Major Depressive Disorder
|
0.320 |
Biomarker
|
disease |
PSYGENET |
This converging cross-species evidence implicates ADCY7 in the modulation of mood regulatory neural mechanisms and, possibly, risk for and pathophysiology of depression, together supporting a continuous dimensional approach to major depressive disorder and other affective disorders.
|
22264442 |
2012 |
Mood Disorders
|
0.310 |
Biomarker
|
group |
BEFREE |
This converging cross-species evidence implicates ADCY7 in the modulation of mood regulatory neural mechanisms and, possibly, risk for and pathophysiology of depression, together supporting a continuous dimensional approach to major depressive disorder and other affective disorders.
|
22264442 |
2012 |
Mood Disorders
|
0.310 |
Biomarker
|
group |
PSYGENET |
This converging cross-species evidence implicates ADCY7 in the modulation of mood regulatory neural mechanisms and, possibly, risk for and pathophysiology of depression, together supporting a continuous dimensional approach to major depressive disorder and other affective disorders.
|
22264442 |
2012 |
Depressed mood
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
This converging cross-species evidence implicates ADCY7 in the modulation of mood regulatory neural mechanisms and, possibly, risk for and pathophysiology of depression, together supporting a continuous dimensional approach to major depressive disorder and other affective disorders.
|
22264442 |
2012 |
Schizophrenia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Exome sequencing supports a de novo mutational paradigm for schizophrenia.
|
21822266 |
2011 |
Alcoholic Intoxication, Chronic
|
0.310 |
Biomarker
|
disease |
PSYGENET |
In the human sample, we found that single nucleotide polymorphisms in ADCY7 associate with alcohol dependence in women, and these markers are also associated with ADCY7 expression (messenger RNA) levels.
|
21481845 |
2011 |
Alcoholic Intoxication, Chronic
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
In the human sample, we found that single nucleotide polymorphisms in ADCY7 associate with alcohol dependence in women, and these markers are also associated with ADCY7 expression (messenger RNA) levels.
|
21481845 |
2011 |